Turnkey Solution Provider of Molecular diagnostics
All our multiplex digital PCR and infection test reagents are independently developed by our in-house team, and our production is certified under the ISO 13485 quality management system.
-
PioneerDigital PCR-based Rapid Detection Solutions for Bloodstream Infections
-
InnovatorInitiator of Multiple Technologies, Committed to Sustained Technological Innovation
-
LeaderLeading Market Share in Domestic Non-Blood-Culture Molecular Diagnostics
Expert Consensus Recommendation
Our solutions are recognized as part of precision medicine applications.
Get To Know Us
Rich Experience
Pilot Gene
Founded in 2014, our company has launched a full portfolio of high-performance products. With growing market recognition, we have been awarded numerous national honors and obtained a host of industry patents.
- Most of domestic top-tier hospital has been our partners.
- We are recognized as National High-Tech Enterprise.
More than 60 publications
More Than 100 Patents
Core Product Advantages
Distinctive Solution edges over competing products in the industry.
Technology Superiorities
-
Absolute QuantificationDirectly generating results in cfDNA copies
-
Strong ToleranceOverall quantification remains stable with inhibitors
-
Ultra-high SensitivitySingle-molecule amplification enables precise Results
CE-IVD
NMPA Ⅲ
ISO13485
ISO9001